192 related articles for article (PubMed ID: 8222654)
1. The presence of mast cells in the human endometrium pre- and post-insertion of intrauterine devices.
Yin M; Zhu P; Luo H; Xu R
Contraception; 1993 Sep; 48(3):245-54. PubMed ID: 8222654
[TBL] [Abstract][Full Text] [Related]
2. The effect of intrauterine devices (stainless steel ring, copper-T220 and levonorgestrel) on the DNA content in isolated human endometrial cells.
Zhu PD; Luo HZ; Cheng J; Xu RH; Liu YF; Zheng WM; Song GY; Chen JH; Zhou ZH; Wu YM
Contraception; 1989 Nov; 40(5):591-604. PubMed ID: 2515028
[TBL] [Abstract][Full Text] [Related]
3. Hormonal intrauterine devices.
Rybo G; Andersson K; Odlind V
Ann Med; 1993 Apr; 25(2):143-7. PubMed ID: 8489751
[TBL] [Abstract][Full Text] [Related]
4. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
[TBL] [Abstract][Full Text] [Related]
5. Endometrial morphological changes in IUD users: a review.
Sheppard BL
Contraception; 1987 Jul; 36(1):1-10. PubMed ID: 3117492
[TBL] [Abstract][Full Text] [Related]
6. A morphometric study on the endometrial activity of women before and after one year with LNG-IUD in situ.
Gu Z; Zhu P; Luo H; Zhu X; Zhang G; Wu S
Contraception; 1995 Jul; 52(1):57-61. PubMed ID: 8521716
[TBL] [Abstract][Full Text] [Related]
7. A risk-benefit assessment of the levonorgestrel-releasing intrauterine system.
Sturridge F; Guillebaud J
Drug Saf; 1996 Dec; 15(6):430-40. PubMed ID: 8968696
[TBL] [Abstract][Full Text] [Related]
8. An evaluation of the levonorgestrel-releasing IUD: its advantages and disadvantages when compared to the copper-releasing IUDs.
Chi IC
Contraception; 1991 Dec; 44(6):573-88. PubMed ID: 1773615
[TBL] [Abstract][Full Text] [Related]
9. Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system.
Critchley HO; Wang H; Kelly RW; Gebbie AE; Glasier AF
Hum Reprod; 1998 May; 13(5):1210-7. PubMed ID: 9647549
[TBL] [Abstract][Full Text] [Related]
10. Levonorgestrel-releasing intrauterine device-wearing women express contraceptive glycodelin A in endometrium during midcycle: another contraceptive mechanism?
Mandelin E; Koistinen H; Koistinen R; Affandi B; Seppälä M
Hum Reprod; 1997 Dec; 12(12):2671-5. PubMed ID: 9455833
[TBL] [Abstract][Full Text] [Related]
11. Two years of intrauterine contraception with levonorgestrel and with copper: a randomized comparison of the TCu 380Ag and levonorgestrel 20 mcg/day devices.
Sivin I; Stern J; Diaz J; Diaz MM; Faundes A; el Mahgoub S; Diaz S; Pavez M; Coutinho E; Mattos CE
Contraception; 1987 Mar; 35(3):245-55. PubMed ID: 3111785
[TBL] [Abstract][Full Text] [Related]
12. Acceptability of an experimental intracervical device: results of a study controlling for selection bias.
Shain RN; Ratsula K; Toivonen J; Lähteenmäki P; Luukkainen T; Holden AE; Rosenthal M
Contraception; 1989 Jan; 39(1):73-84. PubMed ID: 2491982
[TBL] [Abstract][Full Text] [Related]
13. The effect of intrauterine devices, the stainless steel ring, the copper T220, and releasing levonorgestrel, on the bleeding profile and the morphological structure of the human endometrium--a comparative study of three IUDs. A morphometric study of 96 cases.
Zhu PD; Luo HZ; Xu RH; Cheng J; Wu SC; Chen JH; Wu MZ; Wang XP
Contraception; 1989 Oct; 40(4):425-38. PubMed ID: 2510968
[TBL] [Abstract][Full Text] [Related]
14. Endometrial morphometry in users of intrauterine contraceptive devices and women with ovulatory dysfunctional uterine bleeding: a comparison with normal endometrium.
Wang IY; Russell P; Fraser IS
Contraception; 1995 Apr; 51(4):243-8. PubMed ID: 7796590
[TBL] [Abstract][Full Text] [Related]
15. The effects of intrauterine contraceptive devices on the ultrastructure of the endometrium in relation to bleeding complications.
Sheppard BL; Bonnar J
Am J Obstet Gynecol; 1983 Aug; 146(7):829-39. PubMed ID: 6869454
[TBL] [Abstract][Full Text] [Related]
16. Morphological and functional features of endometrial decidualization following long-term intrauterine levonorgestrel delivery.
Critchley HO; Wang H; Jones RL; Kelly RW; Drudy TA; Gebbie AE; Buckley CH; McNeilly AS; Glasier AF
Hum Reprod; 1998 May; 13(5):1218-24. PubMed ID: 9647550
[TBL] [Abstract][Full Text] [Related]
17. Return to fertility after removal of a levonorgestrel-releasing intrauterine device and Nova-T.
Andersson K; Batar I; Rybo G
Contraception; 1992 Dec; 46(6):575-84. PubMed ID: 1493717
[TBL] [Abstract][Full Text] [Related]
18. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
[TBL] [Abstract][Full Text] [Related]
19. Cervical carcinogenesis and contraception.
Misra JS; Engineer AD; Das K; Tandon P
Diagn Cytopathol; 1991; 7(4):346-52. PubMed ID: 1935511
[TBL] [Abstract][Full Text] [Related]
20. Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties.
Luukkainen T; Toivonen J
Contraception; 1995 Nov; 52(5):269-76. PubMed ID: 8585882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
